{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:24:52Z","timestamp":1761218692911,"version":"build-2065373602"},"reference-count":62,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: In clinical practice, neutropenia is frequently accompanied by other cytopenia; isolated non-chemotherapy-induced severe neutropenia is less frequent and its differential diagnosis can be challenging. In this real-world study with data collected over a 5-year period in a tertiary referral hospital, we primarily sought to identify underlying causes of isolated severe neutropenia (&lt;0.5 \u00d7 109\/L). Secondly, we aimed to analyze its management and outcomes. Materials and Methods: From 444,926 screened patients, after exclusion of patients with chemotherapy, radiotherapy, hematological neoplasms, additional cytopenia, and benign ethnic neutropenia, we identified and analyzed data from 70 patients (0.015%) with isolated severe neutropenia. We thus confirmed that the occurrence of isolated severe neutropenia is a rare event, even in a tertiary hospital. Results: The median age at diagnosis was 34 years (range 1\u201381) and 65% were female. Acute neutropenia was more frequently observed (n = 46\/70, 65.7%); the main underlying causes in this group were drugs (n = 36\/46, 78%) followed by infections (n = 10\/46, 21.7%). We identified 24 (34.3%) patients with chronic neutropenia. The majority of them (n = 12\/24, 50%) had an idiopathic form (CIN), 8\/24 (33%) were autoimmune (AIN), and 4\/24 (17%) were congenital. Conclusions: This study demonstrates the rarity and heterogeneity of isolated severe neutropenia and the steps to consider in its diagnostic work-up and management. Epidemiological characteristics, diagnostic work-up, and management including hospitalizations are described. Due to the high frequency of metamizole-induced neutropenia observed in this study, we want to raise awareness about its use, since this complication generates frequent hospitalizations even in young, otherwise healthy patients. Furthermore, recurrent infections in chronic forms of idiopathic neutropenia were quite common, suggesting a difference in phenotypes and need for therapy consideration depending on the clinical course.<\/jats:p>","DOI":"10.3390\/medicina60101576","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T04:05:46Z","timestamp":1727323546000},"page":"1576","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Isolated Severe Neutropenia in Adults, Evaluation of Underlying Causes and Outcomes, Real-World Data Collected over a 5-Year Period in a Tertiary Referral Hospital"],"prefix":"10.3390","volume":"60","author":[{"given":"Linet","family":"Njue","sequence":"first","affiliation":[{"name":"Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-1935","authenticated-orcid":false,"given":"Naomi","family":"Porret","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annatina Sarah","family":"Schnegg-Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca Francesco","family":"Varra","sequence":"additional","affiliation":[{"name":"IDSC-Insel Data Science Centre, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-2988","authenticated-orcid":false,"given":"Martin","family":"Andres","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-4753","authenticated-orcid":false,"given":"Alicia","family":"Rov\u00f3","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminhematol.2013.06.010","article-title":"Evaluation and management of patients with isolated neutropenia","volume":"50","author":"Newburger","year":"2013","journal-title":"Semin. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1098-3597(06)80053-0","article-title":"Neutropenia: Etiology and pathogenesis","volume":"8","author":"Schwartzberg","year":"2006","journal-title":"Clin. Cornerstone"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ibanez","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-013-1618-1","article-title":"Drug-induced agranulocytosis in the Berlin case-control surveillance study","volume":"70","author":"Huber","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14740338.2017.1376645","article-title":"Non-chemotherapy drug-induced neutropenia\u2014An update","volume":"16","author":"Andres","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pascutti, M.F., Erkelens, M.N., and Nolte, M.A. (2016). Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00364"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.4049\/jimmunol.169.11.6193","article-title":"Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha","volume":"169","author":"Sedger","year":"2002","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/pir.29-1-12","article-title":"Neutropenia in pediatric practice","volume":"29","author":"Segel","year":"2008","journal-title":"Pediatr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ejh.13491","article-title":"Haematological manifestations of COVID-19: From cytopenia to coagulopathy","volume":"105","author":"Agbuduwe","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e28866","DOI":"10.1002\/pbc.28866","article-title":"Post-COVID-19 severe neutropenia","volume":"68","author":"Bouslama","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13052-022-01234-5","article-title":"Incidental occurrence of neutropenia in children hospitalised for COVID-19","volume":"48","author":"Folino","year":"2022","journal-title":"Ital. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e242683","DOI":"10.1136\/bcr-2021-242683","article-title":"Febrile neutropenia due to COVID-19 in an immunocompetent patient","volume":"14","author":"Devi","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4269\/ajtmh.2011.11-0154","article-title":"Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa","volume":"85","author":"Olliaro","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2014-02-482612","article-title":"How we evaluate and treat neutropenia in adults","volume":"124","author":"Gibson","year":"2014","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am. J. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rydzynska, Z., Pawlik, B., Krzyzanowski, D., Mlynarski, W., and Madzio, J. (2021). Neutrophil Elastase Defects in Congenital Neutropenia. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.653932"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jclinpath-2018-205235","article-title":"Spectrum of ELANE mutations in congenital neutropenia: A single-centre study in patients of Indian origin","volume":"71","author":"Arun","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2006-08-019166","article-title":"Neutrophil elastase in cyclic and severe congenital neutropenia","volume":"109","author":"Horwitz","year":"2007","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/asheducation-2009.1.344","article-title":"Congenital neutropenia","volume":"2009","author":"Klein","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminhematol.2006.04.004","article-title":"Severe congenital neutropenia","volume":"43","author":"Welte","year":"2006","journal-title":"Semin. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","article-title":"The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","volume":"107","author":"Rosenberg","year":"2006","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e872","DOI":"10.1097\/HS9.0000000000000872","article-title":"The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action","volume":"7","author":"Fioredda","year":"2023","journal-title":"Hemasphere"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e29946","DOI":"10.1002\/pbc.29946","article-title":"Diagnosis and management of isolated neutropenia: A survey of pediatric hematologist oncologists","volume":"70","author":"Gunn","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"521s","DOI":"10.1016\/S0929-693X(03)90061-3","article-title":"Evaluation of neutropenia in children","volume":"10","author":"Donadieu","year":"2003","journal-title":"Arch. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","article-title":"How I diagnose and treat neutropenia","volume":"23","author":"Dale","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ijlh.13210","article-title":"How I investigate neutropenia","volume":"42","author":"Frater","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002512-200421070-00002","article-title":"Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients","volume":"21","author":"Andres","year":"2004","journal-title":"Drugs Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2257.2002.00437.x","article-title":"Nonchemotherapy drug-induced agranulocytosis: Experience of the Strasbourg teaching hospital (1985\u20132000) and review of the literature","volume":"24","author":"Andres","year":"2002","journal-title":"Clin. Lab. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.1992.00400190095018","article-title":"Descriptive epidemiology of agranulocytosis","volume":"152","author":"Strom","year":"1992","journal-title":"Arch. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: Agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00482-014-1490-7","article-title":"Metamizole (dipyrone): Mode of action, drug-drug interactions, and risk of agranulocytosis","volume":"28","author":"Lampl","year":"2014","journal-title":"Schmerz"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","article-title":"Hematological safety of metamizole: Retrospective analysis of WHO and Swiss spontaneous safety reports","volume":"71","author":"Blaser","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","article-title":"Metamizole-induced agranulocytosis revisited: Results from the prospective Berlin Case-Control Surveillance Study","volume":"71","author":"Huber","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bcpt.13310","article-title":"Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985\u20132017","volume":"126","author":"Hoffmann","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","article-title":"Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)","volume":"58","author":"Hedenmalm","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/pan.13257","article-title":"The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review","volume":"27","author":"Dirckx","year":"2017","journal-title":"Paediatr. Anaesth."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"f4366","DOI":"10.1136\/bmj.f4366","article-title":"India\u2019s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen","volume":"347","author":"Bhaumik","year":"2013","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.4906","article-title":"Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review","volume":"29","author":"Li","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40264-023-01319-y","article-title":"Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012\u20132019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate","volume":"46","author":"Beeler","year":"2023","journal-title":"Drug Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10428194.2020.1788017","article-title":"Hematological manifestations of COVID-19","volume":"61","author":"Mina","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1651-2227.1993.tb12696.x","article-title":"Fever and neutropenia: Bacterial etiology revealed by serological methods","volume":"82","author":"Riikonen","year":"1993","journal-title":"Acta Paediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM196811072791902","article-title":"Chronic idiopathic neutropenia. A newly recognized entity?","volume":"279","author":"Kyle","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MOH.0000000000000305","article-title":"An update on the diagnosis and treatment of chronic idiopathic neutropenia","volume":"24","author":"Dale","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0609.2001.00473.x","article-title":"Non-immune chronic idiopathic neutropenia of adult: An overview","volume":"67","author":"Papadaki","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2141.2005.05380.x","article-title":"Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia","volume":"128","author":"Papadaki","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.clim.2010.08.011","article-title":"T-cell receptor Vbeta repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions","volume":"137","author":"Spanoudakis","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOH.0b013e3282f172d3","article-title":"Chronic idiopathic neutropenias and severe congenital neutropenia","volume":"15","author":"Palmblad","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2006.06345.x","article-title":"Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10","volume":"135","author":"Koumaki","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2009.03.006","article-title":"Autoimmune neutropenia in adults","volume":"9","author":"Akhtari","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01698373","article-title":"Autoimmune neutropenia: Clinical and laboratory studies in 143 patients","volume":"63","author":"Bux","year":"1991","journal-title":"Ann. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","article-title":"Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases","volume":"91","author":"Bux","year":"1998","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1537-2995.1997.37997454028.x","article-title":"Report on the second international granulocyte serology workshop","volume":"37","author":"Bux","year":"1997","journal-title":"Transfusion"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ajh.25374","article-title":"Neutropenia in the age of genetic testing: Advances and challenges","volume":"94","author":"Furutani","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood-2006-01-010249","article-title":"Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia","volume":"108","author":"Ancliff","year":"2006","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","article-title":"Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia","volume":"27","author":"Devriendt","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pbc.21282","article-title":"A molecular classification of congenital neutropenia syndromes","volume":"49","author":"Boxer","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0925-5710(95)00407-6","article-title":"CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients","volume":"62","author":"Heussner","year":"1995","journal-title":"Int. J. Hematol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3324\/haematol.2013.099101","article-title":"Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry","volume":"99","author":"Zeidler","year":"2014","journal-title":"Haematologica"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0000000000000602","article-title":"Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia","volume":"125","author":"Boxer","year":"2015","journal-title":"Obstet. Gynecol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1576\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:03:19Z","timestamp":1760112199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["medicina60101576"],"URL":"https:\/\/doi.org\/10.3390\/medicina60101576","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}